Product Images Venlafaxine Hydrochloride

This text appears to be a list of interacting drugs and their impact on a specific analyte, venlafaxine. The drugs listed include ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The text also includes recommendations for concomitant use and dosing adjustments for each drug. The impact of these drugs on the analyte is measured using PK Fold Change and 90% Cl Recommendation. Overall, this text contains valuable information for healthcare professionals.*

This appears to be a table of different drugs and their interactions with each other in terms of PK Fold Change and 90% C Recommendations. The table shows the drugs' cmax and AUC values, and whether there needs to be a dose adjustment, caution in use, or avoidance of concomitant use. There are different recommendations for each drug combination depending on the clinical significance of the combination.*

This text seems to be a table that provides dosing recommendations for different analytes based on the patient's hepatic or renal impairment, age, gender, CYP206 polymorphism, and PK (pharmacokinetics). The dosing adjustments are recommended as either reducing the dose by a certain percentage or individualizing the dosing. The fold change and 90% CI recommendations are also provided for each analyte. Therefore, this text is likely a resource for healthcare professionals to determine appropriate dosing for patients with special populations or conditions.*

This is a pharmaceutical label for Venlafaxine Hydrochloride Extended-Release Capsules USP manufactured by Annora Pharma Private Limited. The label contains dosage, storage, and contact information. It also includes manufacturing details including a lot number and expiration date. The label warns that the unit-dose package is not child-resistant.*

Each capsule contains Venlafaxine Hydrochloride equivalent to 150 mg extended-release USP. The usual dosage is one capsule. Manufacturing details and storage instructions are provided on the capsule bottle. Contact number for US is mentioned.*

This is the label of Venlafaxine Hydrochloride Extended-Release Capsules USP, manufactured by Annora Pharma Private Limited, India. The pack contains 100 capsules, each of which contains Venlafaxine Hydrochloride USP. The pack comes with medication guides for patients. The usual dosage of the capsules, storage conditions, and contact information are also mentioned. The rest of the information is in code and cannot be understood.*

This is a pharmaceutical product information sheet for Venlafaxine Hydrochloride extended-release capsules manufactured by Annora Pharma Private Limited in India. It includes details such as the lot number, expiration date, usual dosage, and storage instructions. The package contains 100 unit-dose capsules, each capsule containing 75mg of venlafaxine hydrochloride USP. The NDC code is 71785-1007-3, and the product is only available with a prescription from a licensed healthcare provider.*

Each capsule contains Venlafaxine Hydrochloride USP equivalent to 75 mg. This medicine comes in a package of 30 capsules. The pharmacist is directed to dispense the Medication Guide provided separately to each patient. For the usual dosage, please refer to the prescribing information. The capsules should be stored at a temperature range of 20°C to 25°C (68°F to 77°F). The product is manufactured by Anora Pharma Private Limited and the US contact number is 1966495-1995. The product is labeled with NDC 7178510070.*